Found 8 hits for monomerid = 230087 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase BTK
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.620 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bristol-Myers Squibb Company
US Patent
| Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), ATP... |
US Patent US9334290 (2016)
BindingDB Entry DOI: 10.7270/Q2BK1B6S |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bristol-Myers Squibb Company
US Patent
| Assay Description The assays were performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substrates ... |
US Patent US9334290 (2016)
BindingDB Entry DOI: 10.7270/Q2BK1B6S |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase BTK
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.620 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bristol-Myers Squibb Company
US Patent
| Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A... |
US Patent US10106559 (2018)
BindingDB Entry DOI: 10.7270/Q2SF2Z7Q |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description Compounds with activity against Jak2 tyrosine kinase have been observed to cause thrombocytopenia, anemia and neutropenia in human patients in clinic... |
US Patent US10435415 (2019)
BindingDB Entry DOI: 10.7270/Q2C53P6V |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase BTK
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.620 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A... |
US Patent US9850258 (2017)
BindingDB Entry DOI: 10.7270/Q27S7R2C |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description The assays were performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and substra... |
US Patent US9850258 (2017)
BindingDB Entry DOI: 10.7270/Q27S7R2C |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase BTK
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.620 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A... |
US Patent US10435415 (2019)
BindingDB Entry DOI: 10.7270/Q2C53P6V |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM230087
(US10106559, Example 9 | US10435415, Example 9 | US...)Show SMILES Cc1c(cccc1-n1c(=O)n(C)c2cc(F)ccc2c1=O)-c1c(Cl)cc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O |(2.09,,;.75,-.77,;-.58,,;-1.92,-.77,;-1.92,-2.31,;-.58,-3.08,;.75,-2.31,;2.09,-3.08,;2.09,-4.62,;.75,-5.39,;3.42,-5.39,;3.42,-6.93,;4.75,-4.62,;6.09,-5.39,;7.42,-4.62,;8.75,-5.39,;7.42,-3.08,;6.09,-2.31,;4.75,-3.08,;3.42,-2.31,;3.42,-.77,;-.58,1.54,;.75,2.31,;2.09,1.54,;.75,3.85,;-.58,4.62,;-.58,6.16,;.75,6.93,;-1.92,6.93,;-1.92,3.85,;-3.38,4.33,;-4.29,3.08,;-5.82,2.92,;-6.44,1.51,;-5.54,.27,;-4.01,.43,;-3.38,1.83,;-1.92,2.31,;-7.98,1.51,;-8.75,.18,;-7.21,.18,;-8.75,2.85,)| Show InChI InChI=1S/C32H26ClFN4O4/c1-15-18(6-5-7-24(15)38-30(40)20-11-9-17(34)13-25(20)37(4)31(38)41)26-22(33)14-21(29(35)39)28-27(26)19-10-8-16(32(2,3)42)12-23(19)36-28/h5-14,36,42H,1-4H3,(H2,35,39) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bristol-Myers Squibb Company
US Patent
| Assay Description Compounds with activity against Jak2 tyrosine kinase have been observed to cause thrombocytopenia, anemia and neutropenia in human patients in clinic... |
US Patent US10106559 (2018)
BindingDB Entry DOI: 10.7270/Q2SF2Z7Q |
More data for this Ligand-Target Pair | |